• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肌醇和 D-手性肌醇(40:1)逆转了多囊卵巢综合征小鼠模型的组织学和功能特征。

Myo-inositol and D-chiro-inositol (40:1) reverse histological and functional features of polycystic ovary syndrome in a mouse model.

机构信息

Department of Dynamic and Clinical Psychology, Sapienza University of Rome and Research Center in Neurobiology Daniel Bovet" (CRiN), Rome, Italy.

Department of Psychology, Sapienza University of Rome, Rome, Italy.

出版信息

J Cell Physiol. 2019 Jun;234(6):9387-9398. doi: 10.1002/jcp.27623. Epub 2018 Oct 14.

DOI:10.1002/jcp.27623
PMID:30317628
Abstract

Mice exposed to continuous light undergo functional and histological changes that mimic those of human Polycystic Ovary Syndrome (PCOS). We herein induced the syndrome by exposing 30-day-old females to 10 weeks of permanent light. Ovarian morphology and histology, as well as reproductive parameters (time of observed pregnancy/delivery) were investigated. Ovaries of PCOS-modeled mice showed lack of tertiary follicles and corpora lutea, altered ovarian architecture, and increased thickness of the theca layer. When mice were returned to a normal light-dark regimen for 10 days, a slight, spontaneous improvement occurred, whereas a quick and almost complete recovery from PCOS signs and symptoms was obtained by treating animals with a daily supplementation of 420 mg/kg myo-inositol and D-chiro-inositol (MyoIns/DCIns) in a 40:1 molar ratio. Namely, ovaries from mice treated by this protocol recovered normal histological features and a proper ratio of theca/granulosa cell layer thickness (TGR), suggesting that the androgenic phenotype was efficiently reversed. Indeed, we identified TGR as a useful index of PCOS, as its increase in PCOS-modeled mice correlated linearly with reduced reproductive capability ( r = 0.75, p < 0.0001). Mice treated with a 40:1 formula regained low TGR values and faster recovery of their fertility, with a physiological delivery time after mating. On the other hand, a higher D-chiro-inositol treatment formula, such as MyoIns versus DCIns 5:1, was ineffective or even had a negative effect on clinical-pathological outcomes.

摘要

持续光照会使小鼠发生功能和组织学变化,这些变化类似于人类多囊卵巢综合征(PCOS)。我们通过让 30 日龄雌性小鼠接受 10 周的持续光照来诱导该综合征。研究了卵巢形态和组织学以及生殖参数(观察到怀孕/分娩的时间)。PCOS 模型小鼠的卵巢缺乏三级卵泡和黄体,卵巢结构发生改变,并且囊外膜层厚度增加。当小鼠恢复正常的明暗周期 10 天时,会出现轻微的自发改善,而通过每天补充 420mg/kg 肌醇和 D-手性肌醇(MyoIns/DCIns)以 40:1 的摩尔比治疗动物,则可以快速且几乎完全从 PCOS 症状和体征中恢复。即,用该方案治疗的小鼠的卵巢恢复了正常的组织学特征和适当的囊外膜/颗粒细胞层厚度比(TGR),表明雄激素表型得到了有效逆转。事实上,我们发现 TGR 是 PCOS 的一个有用指标,因为 PCOS 模型小鼠的 TGR 增加与生殖能力降低呈线性相关(r=0.75,p<0.0001)。用 40:1 配方治疗的小鼠 TGR 值较低,并且更快地恢复生育能力,在交配后具有生理分娩时间。另一方面,更高的 D-手性肌醇治疗配方,如 MyoIns 与 DCIns 5:1,对临床病理结果无效甚至有负面影响。

相似文献

1
Myo-inositol and D-chiro-inositol (40:1) reverse histological and functional features of polycystic ovary syndrome in a mouse model.肌醇和 D-手性肌醇(40:1)逆转了多囊卵巢综合征小鼠模型的组织学和功能特征。
J Cell Physiol. 2019 Jun;234(6):9387-9398. doi: 10.1002/jcp.27623. Epub 2018 Oct 14.
2
Inositol Restores Appropriate Steroidogenesis in PCOS Ovaries Both In Vitro and In Vivo Experimental Mouse Models.肌醇可恢复多囊卵巢综合征卵巢的适当类固醇生成,无论是在体外还是体内实验性小鼠模型中。
Cells. 2024 Jul 9;13(14):1171. doi: 10.3390/cells13141171.
3
High Doses of D-Chiro-Inositol Alone Induce a PCO-Like Syndrome and Other Alterations in Mouse Ovaries.高剂量 D-手性肌醇单独诱导小鼠卵巢 PCO 样综合征和其他改变。
Int J Mol Sci. 2021 May 26;22(11):5691. doi: 10.3390/ijms22115691.
4
Inositols: From Established Knowledge to Novel Approaches.肌醇:从已有知识到新方法。
Int J Mol Sci. 2021 Sep 30;22(19):10575. doi: 10.3390/ijms221910575.
5
Altered Ovarian Inositol Ratios May Account for Pathological Steroidogenesis in PCOS.多囊卵巢综合征中病理性甾体生成的原因可能是卵巢肌醇比值改变。
Int J Mol Sci. 2020 Sep 28;21(19):7157. doi: 10.3390/ijms21197157.
6
The use of inositol(s) isomers in the management of polycystic ovary syndrome: a comprehensive review.肌醇异构体在多囊卵巢综合征管理中的应用:一项综述
Gynecol Endocrinol. 2018 Jul;34(7):545-550. doi: 10.1080/09513590.2017.1421632. Epub 2018 Jan 8.
7
Comparative efficacy of oral insulin sensitizers metformin, thiazolidinediones, inositol, and berberine in improving endocrine and metabolic profiles in women with PCOS: a network meta-analysis.口服胰岛素增敏剂二甲双胍、噻唑烷二酮类、肌醇和小檗碱改善多囊卵巢综合征女性内分泌和代谢谱的疗效比较:网络荟萃分析。
Reprod Health. 2021 Aug 18;18(1):171. doi: 10.1186/s12978-021-01207-7.
8
D-Chiro-inositol and PCOS: between myth and reality. The never-ending story.D-手性肌醇与多囊卵巢综合征:介于神话与现实之间。永无休止的故事。
Int J Food Sci Nutr. 2022 Aug;73(5):565-570. doi: 10.1080/09637486.2022.2029830. Epub 2022 Jan 20.
9
D-Chiro-Inositol Treatment Affects Oocyte and Embryo Quality and Improves Glucose Intolerance in Both Aged Mice and Mouse Models of Polycystic Ovarian Syndrome.D-手性肌醇治疗可改善卵母细胞和胚胎质量,并改善老年小鼠和多囊卵巢综合征小鼠模型的葡萄糖耐量。
Int J Mol Sci. 2020 Aug 22;21(17):6049. doi: 10.3390/ijms21176049.
10
Strategy to improve the female fertility in the general gynecologist's office: use of a nutritional supplement based on myo-inositol/D-chiro-inositol and antioxidants.改善普通妇科医生办公室中女性生育能力的策略:使用基于肌醇/D-手性肌醇和抗氧化剂的营养补充剂。
Gynecol Endocrinol. 2022 Apr;38(4):275-278. doi: 10.1080/09513590.2021.2015759. Epub 2021 Dec 21.

引用本文的文献

1
D-Chiro-Inositol and LPS Induce a PCOS-Like Hyperandrogenic Response in Human KGN Granulosa Cells.D-手性肌醇和脂多糖在人KGN颗粒细胞中诱导出类似多囊卵巢综合征的高雄激素反应。
J Cell Mol Med. 2025 Sep;29(17):e70779. doi: 10.1111/jcmm.70779.
2
Antioxidant and cytokine modulation in PCOS rats protected with probiotics, myo-inositol, and herbal extracts.益生菌、肌醇和草药提取物对多囊卵巢综合征大鼠抗氧化及细胞因子的调节作用。
Vet Med (Praha). 2025 Jun 27;70(6):203-217. doi: 10.17221/116/2024-VETMED. eCollection 2025 Jun.
3
PCOS and Inositols - Advances and Lessons We are Learning. A Narrative Review.
多囊卵巢综合征与肌醇——我们正在汲取的进展与经验。一篇叙述性综述。
Drug Des Devel Ther. 2025 May 21;19:4183-4199. doi: 10.2147/DDDT.S524718. eCollection 2025.
4
D-chiro-inositol effectively counteracts endometriosis in a mouse model.D-手性肌醇在小鼠模型中可有效对抗子宫内膜异位症。
Mol Med. 2025 Apr 11;31(1):134. doi: 10.1186/s10020-025-01178-6.
5
Murine Models and Human Cell Line Models to Study Altered Dynamics of Ovarian Follicles in Polycystic Ovary Syndrome.用于研究多囊卵巢综合征中卵巢卵泡动态变化的小鼠模型和人类细胞系模型
Adv Biol (Weinh). 2025 Jul;9(7):e2400713. doi: 10.1002/adbi.202400713. Epub 2025 Jan 22.
6
Inositol Restores Appropriate Steroidogenesis in PCOS Ovaries Both In Vitro and In Vivo Experimental Mouse Models.肌醇可恢复多囊卵巢综合征卵巢的适当类固醇生成,无论是在体外还是体内实验性小鼠模型中。
Cells. 2024 Jul 9;13(14):1171. doi: 10.3390/cells13141171.
7
Inositols and female reproduction disorders: a consensus statement from the working group of the Club of the Italian Society of Endocrinology (SIE)-Women's Endocrinology.肌醇与女性生殖障碍:意大利内分泌学会(SIE)-女性内分泌学工作组的共识声明。
J Endocrinol Invest. 2024 Sep;47(9):2111-2141. doi: 10.1007/s40618-024-02363-w. Epub 2024 Jul 15.
8
The Effects of Myo-Inositol and D-Chiro-Inositol in a Ratio 40:1 on Hormonal and Metabolic Profile in Women with Polycystic Ovary Syndrome Classified as Phenotype A by the Rotterdam Criteria and EMS-Type 1 by the EGOI Criteria.40:1 配比的肌醇和 D-手性肌醇对按照 Rotterdam 标准分类为表型 A 及按照 EGOI 标准分类为 EMS 类型 1 的多囊卵巢综合征女性的激素和代谢特征的影响。
Gynecol Obstet Invest. 2024;89(2):131-139. doi: 10.1159/000536163. Epub 2024 Jan 31.
9
Inositol for Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis to Inform the 2023 Update of the International Evidence-based PCOS Guidelines.多囊卵巢综合征的肌醇治疗:一项系统评价和荟萃分析,为 2023 年国际循证多囊卵巢综合征指南更新提供信息。
J Clin Endocrinol Metab. 2024 May 17;109(6):1630-1655. doi: 10.1210/clinem/dgad762.
10
Combined Inositols, α-Lactalbumin, Gymnema Sylvestre and Zinc Improve the Lipid Metabolic Profile of Patients with Type 2 Diabetes Mellitus: A Randomized Clinical Trial.联合使用肌醇、α-乳白蛋白、匙羹藤和锌可改善2型糖尿病患者的脂质代谢状况:一项随机临床试验。
J Clin Med. 2023 Dec 13;12(24):7650. doi: 10.3390/jcm12247650.